Barbara Lubrano Di Ciccone, MD

home / authors / barbara-lubrano-di-ciccone-md

Articles

Serotonin Reuptake Inhibitor and Bleeding Risk, Part 2: Gastrointestinal (GI) Bleeding, Malignancy, Pregnancy, and Surgical Considerations

Gregg A. Robbins-Welty, MD, MS;Andrew N. Tuck, MD;Dale Marchant, FRANZCP;Andrew Gleason, FRANZCP;Richard Garrett Key, MD;Barbara Lubrano Di Ciccone, MD;Deepti A. Chopra, MBBS;Mona Mojtahedzadeh, MD;Fíona Fonseca, MD;Hermioni Lokko Amonoo, MD;Andrea DeSimone, DO;Daniel C. McFarland, DO

October 27th 2023

In this CME article, review literature on SRI-related bleeding complications in patients with GI bleeding, malignancy, perioperative settings, pregnancy, and hormonal therapy.

Bleeding Risk With SSRIs, Part 1: Cardiovascular and Cerebrovascular Considerations

September 26th 2023

In this CME article, get a better understanding of bleeding risk associated with use of serotonin reuptake inhibitors (SRIs) and review research-informed literature on related bleeding complications in patients with cardiovascular and cerebrovascular disease.

Group Therapy and Cancer Survival-- Where Does the Evidence Lie in 2007?

Tiffany Floyd, PhD;Barbara Lubrano Di Ciccone, MD;David W. Kissane, MD

June 1st 2007

One of the most hotly debated questions within oncology over the past decade has been whether the promotion of psychological wellness can extend survival for patients with advanced cancer. The converse--that psychiatric disorder shortens survival--seems true, with mechanisms of poor self-care and reduced adherence to anticancer treatments resultant from depressive or psychotic disorders explaining this outcome.